The Gross Margin of Apex Biotechnology Corp (1733.TW) is 28.15%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 28.15% |
| 2023-12-31 | 31.68% |
| 2022-12-31 | 25.70% |
| 2021-12-31 | 26.81% |
| 2020-12-31 | 22.55% |
| 2019-12-31 | 26.86% |
| 2018-12-31 | 27.41% |
| 2017-12-31 | 24.04% |
| 2016-12-31 | 27.04% |
| 2015-12-31 | 29.62% |